342 related articles for article (PubMed ID: 31795417)
21. G-quadruplex located in the 5'UTR of the BAG-1 mRNA affects both its cap-dependent and cap-independent translation through global secondary structure maintenance.
Jodoin R; Carrier JC; Rivard N; Bisaillon M; Perreault JP
Nucleic Acids Res; 2019 Nov; 47(19):10247-10266. PubMed ID: 31504805
[TBL] [Abstract][Full Text] [Related]
22. Identification of the internal ribosome entry sites (IRES) of prion protein gene.
Luo XN; Song QQ; Yu J; Song J; Wang XL; Xia D; Sun P; Han J
Int J Biochem Cell Biol; 2017 Dec; 93():46-51. PubMed ID: 29107182
[TBL] [Abstract][Full Text] [Related]
23. Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets.
Bi J; Chowdhry S; Wu S; Zhang W; Masui K; Mischel PS
Nat Rev Cancer; 2020 Jan; 20(1):57-70. PubMed ID: 31806884
[TBL] [Abstract][Full Text] [Related]
24. Cell Fate Control by Translation: mRNA Translation Initiation as a Therapeutic Target for Cancer Development and Stem Cell Fate Control.
Kim HJ
Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31671902
[TBL] [Abstract][Full Text] [Related]
25. Differential bicistronic gene translation mediated by the internal ribosome entry site element of encephalomyocarditis virus.
Shen CR; Chen YS; Hwang YS; Chen HJ; Liu CL
Biomed J; 2021 Dec; 44(6 Suppl 1):S54-S62. PubMed ID: 35747995
[TBL] [Abstract][Full Text] [Related]
26. Activation of a GPCR leads to eIF4G phosphorylation at the 5' cap and to IRES-dependent translation.
León K; Boulo T; Musnier A; Morales J; Gauthier C; Dupuy L; Heyne S; Backofen R; Poupon A; Cormier P; Reiter E; Crepieux P
J Mol Endocrinol; 2014 Jun; 52(3):373-82. PubMed ID: 24711644
[TBL] [Abstract][Full Text] [Related]
27. Translation acrobatics: how cancer cells exploit alternate modes of translational initiation.
Sriram A; Bohlen J; Teleman AA
EMBO Rep; 2018 Oct; 19(10):. PubMed ID: 30224410
[TBL] [Abstract][Full Text] [Related]
28. Focus on Translation Initiation of the HIV-1 mRNAs.
de Breyne S; Ohlmann T
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597859
[TBL] [Abstract][Full Text] [Related]
29. Current Understanding of Exosomal MicroRNAs in Glioma Immune Regulation and Therapeutic Responses.
Peng J; Liang Q; Xu Z; Cai Y; Peng B; Li J; Zhang W; Kang F; Hong Q; Yan Y; Zhang M
Front Immunol; 2021; 12():813747. PubMed ID: 35095909
[TBL] [Abstract][Full Text] [Related]
30. Targeting IRES-Mediated p53 Synthesis for Cancer Diagnosis and Therapeutics.
Ji B; Harris BR; Liu Y; Deng Y; Gradilone SA; Cleary MP; Liu J; Yang DQ
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054974
[TBL] [Abstract][Full Text] [Related]
31. A researcher's guide to the galaxy of IRESs.
Terenin IM; Smirnova VV; Andreev DE; Dmitriev SE; Shatsky IN
Cell Mol Life Sci; 2017 Apr; 74(8):1431-1455. PubMed ID: 27853833
[TBL] [Abstract][Full Text] [Related]
32. How are circRNAs translated by non-canonical initiation mechanisms?
Diallo LH; Tatin F; David F; Godet AC; Zamora A; Prats AC; Garmy-Susini B; Lacazette E
Biochimie; 2019 Sep; 164():45-52. PubMed ID: 31265859
[TBL] [Abstract][Full Text] [Related]
33. A Sequence-Independent, Unstructured Internal Ribosome Entry Site Is Responsible for Internal Expression of the Coat Protein of Turnip Crinkle Virus.
May J; Johnson P; Saleem H; Simon AE
J Virol; 2017 Apr; 91(8):. PubMed ID: 28179526
[TBL] [Abstract][Full Text] [Related]
34. Deconstructing internal ribosome entry site elements: an update of structural motifs and functional divergences.
Lozano G; Francisco-Velilla R; Martinez-Salas E
Open Biol; 2018 Nov; 8(11):. PubMed ID: 30487301
[TBL] [Abstract][Full Text] [Related]
35. The challenges and the promise of molecular targeted therapy in malignant gliomas.
Wang H; Xu T; Jiang Y; Xu H; Yan Y; Fu D; Chen J
Neoplasia; 2015 Mar; 17(3):239-55. PubMed ID: 25810009
[TBL] [Abstract][Full Text] [Related]
36. Cap-Independent Translational Control of Carcinogenesis.
Walters B; Thompson SR
Front Oncol; 2016; 6():128. PubMed ID: 27252909
[TBL] [Abstract][Full Text] [Related]
37. P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.
Zou H; Wen C; Peng Z; Shao YΥ; Hu L; Li S; Li C; Zhou HH
Oncol Rep; 2018 Feb; 39(2):501-510. PubMed ID: 29207176
[TBL] [Abstract][Full Text] [Related]
38. Construction of regulatable picornavirus IRESes as a test of current models of the mechanism of internal translation initiation.
Pöyry TA; Hentze MW; Jackson RJ
RNA; 2001 May; 7(5):647-60. PubMed ID: 11350029
[TBL] [Abstract][Full Text] [Related]
39. Rediscovering Potential Molecular Targets for Glioma Therapy Through the Analysis of the Cell of Origin, Microenvironment and Metabolism.
Guo X; Wang T; Huang G; Li R; Da Costa C; Li H; Lv S; Li N
Curr Cancer Drug Targets; 2021; 21(7):558-574. PubMed ID: 33949933
[TBL] [Abstract][Full Text] [Related]
40. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
